Difference between revisions of "Part:BBa K4601041:Design"
Line 7: | Line 7: | ||
===Design Notes=== | ===Design Notes=== | ||
− | |||
+ | To disrupt the BsaI recognition site GGTCTC by site-directed mutagenesis we choose to change its sequence to GGTCGC. Care was taken that the mutation should not affect the amino acid composition of the protein. The chosen mutation is a synonymous one TCT(Ser) to TCG(Ser). | ||
+ | >BsaI | ||
+ | | | ||
+ | pSB1A3: 1171 - GGG TCT CGC - 1179 | ||
+ | G S R | ||
+ | |||
+ | BBa K4601041: 715 - GGG TCG CGC - 723 | ||
+ | G S R | ||
− | |||
− | + | ===Source=== | |
− | + | PCR amplification from a BsaI-free version of pSB1A3 |
Latest revision as of 20:23, 2 October 2023
AmpR
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
To disrupt the BsaI recognition site GGTCTC by site-directed mutagenesis we choose to change its sequence to GGTCGC. Care was taken that the mutation should not affect the amino acid composition of the protein. The chosen mutation is a synonymous one TCT(Ser) to TCG(Ser).
>BsaI | pSB1A3: 1171 - GGG TCT CGC - 1179 G S R BBa K4601041: 715 - GGG TCG CGC - 723 G S R
Source
PCR amplification from a BsaI-free version of pSB1A3